Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Semin Cancer Biol. 2020 Aug;64:13-18. doi: 10.1016/j.semcancer.2019.05.014. Epub 2019 May 23.
Glioblastoma (GBM) is an aggressive and incurable brain tumor; its malignancy has been associated with the activity of tumor infiltrating myeloid cells. Myeloid cells play important roles in the tumor control by the immune response, but also in tumor progression. Indeed, GBM exploits multiple mechanisms to recruit and modulate myeloid cells. The Aryl Hydrocarbon Receptor (AHR) is a ligand activated transcription factor implicated in the regulation of myeloid cells. In this review, we will summarize current knowledge on the AHR role in the control of myeloid cells and its impact on GBM pathogenesis.
胶质母细胞瘤(GBM)是一种侵袭性和无法治愈的脑肿瘤;其恶性程度与肿瘤浸润性髓样细胞的活性有关。髓样细胞在肿瘤免疫反应的控制中发挥着重要作用,但也在肿瘤的进展中发挥作用。事实上,GBM 利用多种机制来招募和调节髓样细胞。芳香烃受体(AHR)是一种配体激活的转录因子,参与髓样细胞的调节。在这篇综述中,我们将总结 AHR 在控制髓样细胞及其对 GBM 发病机制影响方面的最新知识。